Eiry Roberts

Eiry Roberts

Chief Tech/Sci/R&D Officer at NEUROCRINE BIOSCIENCES, INC.

Net worth: 8 M $ as of 31/10/2026

62 year
Health Technology
Consumer Services
Commercial Services

Profile

Presently, Eiry W. Roberts is Chief Medical Officer of Neurocrine Biosciences, Inc. In her past career she held the position of Vice President-Clinical Pharmacology & MD at Eli Lilly & Co. She received a doctorate from the University of London.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/11/2026 51,331 ( 0.05% ) 7 M $ 31/10/2026
22/05/2026 45,871 ( 0.01% ) 376 142 $ 31/10/2026

Eiry Roberts active positions

CompaniesPositionStart
NEUROCRINE BIOSCIENCES, INC. Chief Tech/Sci/R&D Officer 28/09/2026
BAUSCH HEALTH COMPANIES INC. Director/Board Member 19/05/2026
Corporate Officer/Principal -

Former positions of Eiry Roberts

CompaniesPositionEnd
AMICUS THERAPEUTICS, INC. Director/Board Member 27/04/2026
NEUROCRINE BIOSCIENCES, INC. Chief Tech/Sci/R&D Officer 02/06/2025
ELI LILLY AND COMPANY Corporate Officer/Principal 01/12/2017
Corporate Officer/Principal -
Director/Board Member -
See the detail of Eiry Roberts's experience

Education of Eiry Roberts

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

71

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Consumer Services